| Generation of pig induced pluripotent stem cells with a drug-inducible system Z Wu, J Chen, J Ren, L Bao, J Liao, C Cui, L Rao, H Li, Y Gu, H Dai, ... Journal of molecular cell biology 1 (1), 46-54, 2009 | 529 | 2009 |
| Engineering human pluripotent stem cells into a functional skeletal muscle tissue L Rao, Y Qian, A Khodabukus, T Ribar, N Bursac Nature communications 9 (1), 126, 2018 | 285 | 2018 |
| Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors J Liao, Z Wu, Y Wang, L Cheng, C Cui, Y Gao, T Chen, L Rao, S Chen, ... Cell research 18 (5), 600-603, 2008 | 269 | 2008 |
| Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors L Bao, L He, J Chen, Z Wu, J Liao, L Rao, J Ren, H Li, H Zhu, L Qian, ... Cell research 21 (4), 600-608, 2011 | 165 | 2011 |
| Engineered skeletal muscles for disease modeling and drug discovery J Wang, A Khodabukus, L Rao, K Vandusen, N Abutaleb, N Bursac Biomaterials 221, 119416, 2019 | 86 | 2019 |
| Generation of hircine-induced pluripotent stem cells by somatic cell reprogramming J Ren, Y Pak, L He, L Qian, Y Gu, H Li, L Rao, J Liao, C Cui, X Xu, J Zhou, ... Cell research 21 (5), 849-853, 2011 | 81 | 2011 |
| Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin P Lu, J Chen, L He, J Ren, H Chen, L Rao, Q Zhuang, H Li, L Li, L Bao, ... Stem Cell Reviews and Reports 9, 806-813, 2013 | 75 | 2013 |
| Highly efficient derivation of skeletal myotubes from human embryonic stem cells L Rao, W Tang, Y Wei, L Bao, J Chen, H Chen, L He, P Lu, J Ren, L Wu, ... Stem Cell Reviews and Reports 8, 1109-1119, 2012 | 41 | 2012 |
| Exercise mimetics and JAK inhibition attenuate IFN-γ–induced wasting in engineered human skeletal muscle Z Chen, B Li, RZ Zhan, L Rao, N Bursac Science Advances 7 (4), eabd9502, 2021 | 40 | 2021 |
| p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming L Gong, X Pan, H Chen, L Rao, Y Zeng, H Hang, J Peng, L Xiao, J Chen Scientific Reports 6 (1), 37281, 2016 | 28 | 2016 |
| Generating hESCs with reduced immunogenicity by disrupting TAP1 or TAPBP D Cui, J Wang, Y Zeng, L Rao, H Chen, W Li, Y Li, H Li, C Cui, L Xiao Bioscience, biotechnology, and biochemistry 80 (8), 1484-1491, 2016 | 20 | 2016 |
| Derivation and characterization of human embryonic stem cell lines from the Chinese population Z Wu, H Li, L Rao, L He, L Bao, J Liao, C Cui, Z Zuo, Q Li, H Dai, L Qian, ... Journal of Genetics and Genomics 38 (1), 13-20, 2011 | 18 | 2011 |
| Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium RZ Zhan, L Rao, Z Chen, N Strash, N Bursac Acta biomaterialia 126, 144-153, 2021 | 13 | 2021 |
| Engineering human pluripotent stem cells into a functional skeletal muscle tissue. Nat Commun 9 (1): 126 L Rao, Y Qian, A Khodabukus, T Ribar, N Bursac | 10 | 2018 |
| Generation and application of human iPS cells C Cui, LJ Rao, LZ Cheng, L Xiao Chinese Science Bulletin 54 (1), 9-13, 2009 | 6 | 2009 |
| Generation of pig-induced pluripotent stem cells with a drug-inducible system (vol 1, pg 46, 2009) Z Wu, J Chen, J Ren, L Bao, J Liao, C Cui, L Rao, H Li, Y Gu, H Dai, ... Journal of Molecular Cell Biology 2 (2), 104-104, 2010 | 2 | 2010 |
| Contractile hPSC derived Skeletal Muscle Tissues for Human Disease Modeling L Rao, Y Qian, A Khodabukus, T Ribar, N Bursac TISSUE ENGINEERING PART A 23, S128-S128, 2017 | | 2017 |
Jiangtao RenUniversity of PennsylvaniaVerified email at mail.med.upenn.edu
